Latest News
Druckenmiller is considered one of the best investors of all time.
Via The Motley Fool · September 9, 2026
Broadcom recently delivered a substantial update about future revenue, and that forecast is not yet being reflected in its stock price.
Via The Motley Fool · September 9, 2026
Two of Wall Street’s premier artificial intelligence (AI) stocks are set to pay approximately $24.2 billion and $27.1 billion in dividends over the next year.
Via The Motley Fool · September 9, 2026
Regeneron Pharmaceuticals (NASDAQ:REGN): A Credible Value Stock With a Meaningful Discountchartmill.com
Via Chartmill · September 9, 2026
Biofrontera (NASDAQ:BFRI) Passes Minervini Trend Template With High-Growth Momentumchartmill.com
Via Chartmill · September 9, 2026
PayPal shares fell after Stripe and Advent's $60.50-per-share buyout collapsed, but strong Q2 earnings, a low P/E ratio, and stablecoin growth suggest the stock still has appeal.
Via MarketBeat · September 9, 2026
Chevron has its eye on a big prize in Venezuela. Getting there in its desired timeline may be a different matter.
Via The Motley Fool · September 9, 2026
E-commerce pet food and supplies retailer Chewy (NYSE:CHWY) met Wall Street’s revenue expectations in Q2 CY2026, with sales up 7.3% year on year to $3.33 bil...
Via StockStory · September 9, 2026
Organizational consulting firm Korn Ferry (NYSE:KFY) announced better-than-expected revenue in Q2 CY2026, with sales up 6.9% year on year to $764.6 million. ...
Via StockStory · September 9, 2026
Dividend growth stocks have historically been the least volatile.
Via The Motley Fool · September 9, 2026
Editas Medicine (NASDAQ:EDIT) is preparing to begin a first-in-human study of EDIT-401, an in vivo CRISPR-edited medicine designed to lower LDL cholesterol in patients with heterozygous familial hypercholesterolemia, Chief Executive Officer Gilmore O’Neill said during a Wells Fargo discussion.
O’Ne
Via MarketBeat · September 9, 2026
https://southern-roofing-1.jimdosite.com/Flat roofs on kitchen extensions can blister and crack over time. When you search for Roofers Near Me Balham, you
Via Talk Markets · September 9, 2026
Casey's General Stores shares are trading lower Wednesday despite reporting better-than-expected Q1 earnings late Tuesday.
Via Benzinga · September 9, 2026
Tesla's future may finally be arriving, but it doesn't automatically make the stock a buy.
Via The Motley Fool · September 9, 2026
This chipmaker is poised to benefit from the long-term trend.
Via The Motley Fool · September 9, 2026
Despite its tumble this year, analysts see a brighter future for Oklo than for NuScale.
Via The Motley Fool · September 9, 2026
Enjoy a comfortable stay at the Best Hotel in Mahipalpur Delhi with clean rooms, WiFi, air conditioning, and convenient access to IGI Airport. Book now.htt
Via Talk Markets · September 9, 2026
AeroVironment reports earnings Sept. 9; analysts expect 25¢ EPS on $456M revenue. The company also won a $464.8M Army laser contract.
Via Benzinga · September 9, 2026
Meta Platforms is trending Wednesday after it announced Muse, a personal AI agent built to help users manage tasks and achieve goals.
Via Benzinga · September 9, 2026
Investors eye high-yield industrial stocks: UPS (6.53%), Robert Half (6.02%) and Watsco (4.18%), with recent analyst ratings and news.
Via Benzinga · September 9, 2026

Holiday travel is a great opportunity to spend quality time with family, friends, coworkers, or community groups, but arranging transportation for everyone
Via Talk Markets · September 9, 2026
Elon Musk says NASA should redeploy SLS workers as its costly legacy rocket faces scrutiny and Artemis shifts to commercial launch systems.
Via Benzinga · September 9, 2026
Le Premier Hotel in Mahipalpur Delhi offers comfy rooms, free Wi-Fi, air conditioning, and great safety near IGI Airport. Book your stay today. https://map
Via Talk Markets · September 9, 2026
Security and convenient communication are becoming increasingly important for homeowners and property managers across New Zealand. A reliable intercom syst
Via Talk Markets · September 9, 2026
Evommune halts EVO756 development in atopic dermatitis following a Phase 2b trial failure, shifting focus to its EVO301 candidate.
Via Benzinga · September 9, 2026